Belimumab for the treatment of pemphigus

Dermatol Ther. 2022 Aug;35(8):e15621. doi: 10.1111/dth.15621. Epub 2022 Jul 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic*
  • Pemphigus* / diagnosis
  • Pemphigus* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • belimumab